- call +1-201-465-4211
- email sales@mrinsights.biz
According to this latest study, the 2021 growth of MRD (Minimal Residual Disease) Testing will have significant change from previous year. By the most conservative estimates of global MRD (Minimal Residual Disease) Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX million in 2020. Over the next five years the MRD (Minimal Residual Disease) Testing market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of MRD (Minimal Residual Disease) Testing market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Flow Cytometry
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Specialty Clinics and Hospitals
Diagnostic Laboratories
Research Institutions
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
ICON plc
ArcherDX(Invitae)
ARUP Laboratories
Asuragen
Cergentis B.V.
Bio-Rad Laboratories
Mission Bio
Guardant Health
Invivoscribe
LabCorp
Inivata
Natera
NeoGenomics Laboratories
Opko Health
Quest Diagnostics
Sysmex Corporation
Adaptive Biotechnologies
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global MRD (Minimal Residual Disease) Testing Consumption 2016-2026
2.1.2 MRD (Minimal Residual Disease) Testing Consumption CAGR by Region
2.2 MRD (Minimal Residual Disease) Testing Segment by Type
2.2.1 Flow Cytometry
2.2.2 Polymerase Chain Reaction (PCR)
2.2.3 Next-Generation Sequencing (NGS)
2.3 MRD (Minimal Residual Disease) Testing Sales by Type
2.3.1 Global MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2016-2021)
2.3.2 Global MRD (Minimal Residual Disease) Testing Revenue and Market Share by Type (2016-2021)
2.3.3 Global MRD (Minimal Residual Disease) Testing Sale Price by Type (2016-2021)
2.4 MRD (Minimal Residual Disease) Testing Segment by Application
2.4.1 Specialty Clinics and Hospitals
2.4.2 Diagnostic Laboratories
2.4.3 Research Institutions
2.5 MRD (Minimal Residual Disease) Testing Sales by Application
2.5.1 Global MRD (Minimal Residual Disease) Testing Sale Market Share by Application (2016-2021)
2.5.2 Global MRD (Minimal Residual Disease) Testing Revenue and Market Share by Application (2016-2021)
2.5.3 Global MRD (Minimal Residual Disease) Testing Sale Price by Application (2016-2021)
3 Global MRD (Minimal Residual Disease) Testing by Company
3.1 Global MRD (Minimal Residual Disease) Testing Sales Market Share by Company
3.1.1 Global MRD (Minimal Residual Disease) Testing Sales by Company (2019-2021)
3.1.2 Global MRD (Minimal Residual Disease) Testing Sales Market Share by Company (2019-2021)
3.2 Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Company
3.2.1 Global MRD (Minimal Residual Disease) Testing Revenue by Company (2019-2021)
3.2.2 Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Company (2019-2021)
3.3 Global MRD (Minimal Residual Disease) Testing Sale Price by Company
3.4 Global Manufacturers MRD (Minimal Residual Disease) Testing Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers MRD (Minimal Residual Disease) Testing Product Location Distribution
3.4.2 Players MRD (Minimal Residual Disease) Testing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 MRD (Minimal Residual Disease) Testing by Region
4.1 Global MRD (Minimal Residual Disease) Testing by Region
4.1.1 Global MRD (Minimal Residual Disease) Testing Sales by Region
4.1.2 Global MRD (Minimal Residual Disease) Testing Revenue by Region
4.2 Americas MRD (Minimal Residual Disease) Testing Sales Growth
4.3 APAC MRD (Minimal Residual Disease) Testing Sales Growth
4.4 Europe MRD (Minimal Residual Disease) Testing Sales Growth
4.5 Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Growth
5 Americas
5.1 Americas MRD (Minimal Residual Disease) Testing Sales by Country
5.1.1 Americas MRD (Minimal Residual Disease) Testing Sales by Country (2016-2021)
5.1.2 Americas MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2021)
5.2 Americas MRD (Minimal Residual Disease) Testing Sales by Type
5.3 Americas MRD (Minimal Residual Disease) Testing Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC MRD (Minimal Residual Disease) Testing Sales by Region
6.1.1 APAC MRD (Minimal Residual Disease) Testing Sales by Region (2016-2021)
6.1.2 APAC MRD (Minimal Residual Disease) Testing Revenue by Region (2016-2021)
6.2 APAC MRD (Minimal Residual Disease) Testing Sales by Type
6.3 APAC MRD (Minimal Residual Disease) Testing Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe MRD (Minimal Residual Disease) Testing by Country
7.1.1 Europe MRD (Minimal Residual Disease) Testing Sales by Country (2016-2021)
7.1.2 Europe MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2021)
7.2 Europe MRD (Minimal Residual Disease) Testing Sales by Type
7.3 Europe MRD (Minimal Residual Disease) Testing Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa MRD (Minimal Residual Disease) Testing by Country
8.1.1 Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Country (2016-2021)
8.1.2 Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2021)
8.2 Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Type
8.3 Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 MRD (Minimal Residual Disease) Testing Distributors
10.3 MRD (Minimal Residual Disease) Testing Customer
11 Global MRD (Minimal Residual Disease) Testing Market Forecast
11.1 Global MRD (Minimal Residual Disease) Testing Forecast by Region
11.1.1 Global MRD (Minimal Residual Disease) Testing Forecast by Regions (2021-2026)
11.2.2 Global MRD (Minimal Residual Disease) Testing Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global MRD (Minimal Residual Disease) Testing Forecast by Type
11.7 Global MRD (Minimal Residual Disease) Testing Forecast by Application
12 Key Players Analysis
12.1 ICON plc
12.1.1 ICON plc Company Information
12.1.2 ICON plc MRD (Minimal Residual Disease) Testing Product Offered
12.1.3 ICON plc MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 ICON plc Main Business Overview
12.1.5 ICON plc Latest Developments
12.2 ArcherDX(Invitae)
12.2.1 ArcherDX(Invitae) Company Information
12.2.2 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product Offered
12.2.3 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 ArcherDX(Invitae) Main Business Overview
12.2.5 ArcherDX(Invitae) Latest Developments
12.3 ARUP Laboratories
12.3.1 ARUP Laboratories Company Information
12.3.2 ARUP Laboratories MRD (Minimal Residual Disease) Testing Product Offered
12.3.3 ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 ARUP Laboratories Main Business Overview
12.3.5 ARUP Laboratories Latest Developments
12.4 Asuragen
12.4.1 Asuragen Company Information
12.4.2 Asuragen MRD (Minimal Residual Disease) Testing Product Offered
12.4.3 Asuragen MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Asuragen Main Business Overview
12.4.5 Asuragen Latest Developments
12.5 Cergentis B.V.
12.5.1 Cergentis B.V. Company Information
12.5.2 Cergentis B.V. MRD (Minimal Residual Disease) Testing Product Offered
12.5.3 Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Cergentis B.V. Main Business Overview
12.5.5 Cergentis B.V. Latest Developments
12.6 Bio-Rad Laboratories
12.6.1 Bio-Rad Laboratories Company Information
12.6.2 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product Offered
12.6.3 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Bio-Rad Laboratories Main Business Overview
12.6.5 Bio-Rad Laboratories Latest Developments
12.7 Mission Bio
12.7.1 Mission Bio Company Information
12.7.2 Mission Bio MRD (Minimal Residual Disease) Testing Product Offered
12.7.3 Mission Bio MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Mission Bio Main Business Overview
12.7.5 Mission Bio Latest Developments
12.8 Guardant Health
12.8.1 Guardant Health Company Information
12.8.2 Guardant Health MRD (Minimal Residual Disease) Testing Product Offered
12.8.3 Guardant Health MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Guardant Health Main Business Overview
12.8.5 Guardant Health Latest Developments
12.9 Invivoscribe
12.9.1 Invivoscribe Company Information
12.9.2 Invivoscribe MRD (Minimal Residual Disease) Testing Product Offered
12.9.3 Invivoscribe MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Invivoscribe Main Business Overview
12.9.5 Invivoscribe Latest Developments
12.10 LabCorp
12.10.1 LabCorp Company Information
12.10.2 LabCorp MRD (Minimal Residual Disease) Testing Product Offered
12.10.3 LabCorp MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 LabCorp Main Business Overview
12.10.5 LabCorp Latest Developments
12.11 Inivata
12.11.1 Inivata Company Information
12.11.2 Inivata MRD (Minimal Residual Disease) Testing Product Offered
12.11.3 Inivata MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Inivata Main Business Overview
12.11.5 Inivata Latest Developments
12.12 Natera
12.12.1 Natera Company Information
12.12.2 Natera MRD (Minimal Residual Disease) Testing Product Offered
12.12.3 Natera MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Natera Main Business Overview
12.12.5 Natera Latest Developments
12.13 NeoGenomics Laboratories
12.13.1 NeoGenomics Laboratories Company Information
12.13.2 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product Offered
12.13.3 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 NeoGenomics Laboratories Main Business Overview
12.13.5 NeoGenomics Laboratories Latest Developments
12.14 Opko Health
12.14.1 Opko Health Company Information
12.14.2 Opko Health MRD (Minimal Residual Disease) Testing Product Offered
12.14.3 Opko Health MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Opko Health Main Business Overview
12.14.5 Opko Health Latest Developments
12.15 Quest Diagnostics
12.15.1 Quest Diagnostics Company Information
12.15.2 Quest Diagnostics MRD (Minimal Residual Disease) Testing Product Offered
12.15.3 Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Quest Diagnostics Main Business Overview
12.15.5 Quest Diagnostics Latest Developments
12.16 Sysmex Corporation
12.16.1 Sysmex Corporation Company Information
12.16.2 Sysmex Corporation MRD (Minimal Residual Disease) Testing Product Offered
12.16.3 Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Sysmex Corporation Main Business Overview
12.16.5 Sysmex Corporation Latest Developments
12.17 Adaptive Biotechnologies
12.17.1 Adaptive Biotechnologies Company Information
12.17.2 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product Offered
12.17.3 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Adaptive Biotechnologies Main Business Overview
12.17.5 Adaptive Biotechnologies Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. MRD (Minimal Residual Disease) Testing Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Flow Cytometry
Table 3. Major Players of Polymerase Chain Reaction (PCR)
Table 4. Major Players of Next-Generation Sequencing (NGS)
Table 5. Global MRD (Minimal Residual Disease) Testing Sales by Type (2016-2021) & (Units)
Table 6. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2016-2021)
Table 7. Global MRD (Minimal Residual Disease) Testing Revenue by Type (2016-2021) & ($ million)
Table 8. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2016-2021)
Table 9. Global MRD (Minimal Residual Disease) Testing Sale Price by Type (2016-2021)
Table 10. Global MRD (Minimal Residual Disease) Testing Sales by Application (2016-2021) & (Units)
Table 11. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2016-2021)
Table 12. Global MRD (Minimal Residual Disease) Testing Value by Application (2016-2021)
Table 13. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Application (2016-2021)
Table 14. Global MRD (Minimal Residual Disease) Testing Sale Price by Application (2016-2021)
Table 15. Global MRD (Minimal Residual Disease) Testing Sales by Company (2019-2021) & (Units)
Table 16. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Company (2019-2021)
Table 17. Global MRD (Minimal Residual Disease) Testing Revenue by Company (2019-2021) ($ Millions)
Table 18. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Company (2019-2021)
Table 19. Global MRD (Minimal Residual Disease) Testing Sale Price by Company (2019-2021)
Table 20. Key Manufacturers MRD (Minimal Residual Disease) Testing Producing Area Distribution and Sales Area
Table 21. Players MRD (Minimal Residual Disease) Testing Products Offered
Table 22. MRD (Minimal Residual Disease) Testing Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global MRD (Minimal Residual Disease) Testing Sales by Region (2016-2021) (Units)
Table 26. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2016-2021)
Table 27. Global MRD (Minimal Residual Disease) Testing Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Region (2016-2021)
Table 29. Americas MRD (Minimal Residual Disease) Testing Sales by Country (2016-2021) & (Units)
Table 30. Americas MRD (Minimal Residual Disease) Testing Sales Market Share by Country (2016-2021)
Table 31. Americas MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas MRD (Minimal Residual Disease) Testing Revenue Market Share by Country (2016-2021)
Table 33. Americas MRD (Minimal Residual Disease) Testing Sales by Type (2016-2021) & (Units)
Table 34. Americas MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2016-2021)
Table 35. Americas MRD (Minimal Residual Disease) Testing Sales by Application (2016-2021) & (Units)
Table 36. Americas MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2016-2021)
Table 37. APAC MRD (Minimal Residual Disease) Testing Sales by Region (2016-2021) & (Units)
Table 38. APAC MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2016-2021)
Table 39. APAC MRD (Minimal Residual Disease) Testing Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC MRD (Minimal Residual Disease) Testing Revenue Market Share by Region (2016-2021)
Table 41. APAC MRD (Minimal Residual Disease) Testing Sales by Type (2016-2021) & (Units)
Table 42. APAC MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2016-2021)
Table 43. APAC MRD (Minimal Residual Disease) Testing Sales by Application (2016-2021) & (Units)
Table 44. APAC MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2016-2021)
Table 45. Europe MRD (Minimal Residual Disease) Testing Sales by Country (2016-2021) & (Units)
Table 46. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Country (2016-2021)
Table 47. Europe MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe MRD (Minimal Residual Disease) Testing Revenue Market Share by Country (2016-2021)
Table 49. Europe MRD (Minimal Residual Disease) Testing Sales by Type (2016-2021) & (Units)
Table 50. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2016-2021)
Table 51. Europe MRD (Minimal Residual Disease) Testing Sales by Application (2016-2021) & (Units)
Table 52. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Country (2016-2021) & (Units)
Table 54. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Type (2016-2021) & (Units)
Table 58. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Application (2016-2021) & (Units)
Table 60. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of MRD (Minimal Residual Disease) Testing
Table 62. Key Application and Potential Industries of MRD (Minimal Residual Disease) Testing
Table 63. Key Challenges of MRD (Minimal Residual Disease) Testing
Table 64. Key Trends of MRD (Minimal Residual Disease) Testing
Table 65. MRD (Minimal Residual Disease) Testing Distributors List
Table 66. MRD (Minimal Residual Disease) Testing Customer List
Table 67. Global MRD (Minimal Residual Disease) Testing Sales Forecast by Region (2021-2026) & (Units)
Table 68. Global MRD (Minimal Residual Disease) Testing Consumption Market Forecast by Region
Table 69. Global MRD (Minimal Residual Disease) Testing Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global MRD (Minimal Residual Disease) Testing Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas MRD (Minimal Residual Disease) Testing Sales Forecast by Country (2021-2026) & (Units)
Table 72. Americas MRD (Minimal Residual Disease) Testing Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC MRD (Minimal Residual Disease) Testing Sales Forecast by Region (2021-2026) & (Units)
Table 74. APAC MRD (Minimal Residual Disease) Testing Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe MRD (Minimal Residual Disease) Testing Sales Forecast by Country (2021-2026) & (Units)
Table 76. Europe MRD (Minimal Residual Disease) Testing Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Forecast by Country (2021-2026) & (Units)
Table 78. Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global MRD (Minimal Residual Disease) Testing Sales Forecast by Type (2021-2026) & (Units)
Table 80. Global MRD (Minimal Residual Disease) Testing Sales Market Share Forecast by Type (2021-2026)
Table 81. Global MRD (Minimal Residual Disease) Testing Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global MRD (Minimal Residual Disease) Testing Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global MRD (Minimal Residual Disease) Testing Sales Forecast by Application (2021-2026) & (Units)
Table 84. Global MRD (Minimal Residual Disease) Testing Sales Market Share Forecast by Application (2021-2026)
Table 85. Global MRD (Minimal Residual Disease) Testing Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global MRD (Minimal Residual Disease) Testing Revenue Market Share Forecast by Application (2021-2026)
Table 87. ICON plc Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 88. ICON plc MRD (Minimal Residual Disease) Testing Product Offered
Table 89. ICON plc MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 90. ICON plc Main Business
Table 91. ICON plc Latest Developments
Table 92. ArcherDX(Invitae) Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 93. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product Offered
Table 94. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 95. ArcherDX(Invitae) Main Business
Table 96. ArcherDX(Invitae) Latest Developments
Table 97. ARUP Laboratories Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 98. ARUP Laboratories MRD (Minimal Residual Disease) Testing Product Offered
Table 99. ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 100. ARUP Laboratories Main Business
Table 101. ARUP Laboratories Latest Developments
Table 102. Asuragen Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 103. Asuragen MRD (Minimal Residual Disease) Testing Product Offered
Table 104. Asuragen MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 105. Asuragen Main Business
Table 106. Asuragen Latest Developments
Table 107. Cergentis B.V. Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 108. Cergentis B.V. MRD (Minimal Residual Disease) Testing Product Offered
Table 109. Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 110. Cergentis B.V. Main Business
Table 111. Cergentis B.V. Latest Developments
Table 112. Bio-Rad Laboratories Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 113. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product Offered
Table 114. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 115. Bio-Rad Laboratories Main Business
Table 116. Bio-Rad Laboratories Latest Developments
Table 117. Mission Bio Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 118. Mission Bio MRD (Minimal Residual Disease) Testing Product Offered
Table 119. Mission Bio MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 120. Mission Bio Main Business
Table 121. Mission Bio Latest Developments
Table 122. Guardant Health Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 123. Guardant Health MRD (Minimal Residual Disease) Testing Product Offered
Table 124. Guardant Health MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 125. Guardant Health Main Business
Table 126. Guardant Health Latest Developments
Table 127. Invivoscribe Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 128. Invivoscribe MRD (Minimal Residual Disease) Testing Product Offered
Table 129. Invivoscribe MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 130. Invivoscribe Main Business
Table 131. Invivoscribe Latest Developments
Table 132. LabCorp Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 133. LabCorp MRD (Minimal Residual Disease) Testing Product Offered
Table 134. LabCorp MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 135. LabCorp Main Business
Table 136. LabCorp Latest Developments
Table 137. Inivata Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 138. Inivata MRD (Minimal Residual Disease) Testing Product Offered
Table 139. Inivata MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 140. Inivata Main Business
Table 141. Inivata Latest Developments
Table 142. Natera Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 143. Natera MRD (Minimal Residual Disease) Testing Product Offered
Table 144. Natera MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 145. Natera Main Business
Table 146. Natera Latest Developments
Table 147. NeoGenomics Laboratories Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 148. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product Offered
Table 149. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 150. NeoGenomics Laboratories Main Business
Table 151. NeoGenomics Laboratories Latest Developments
Table 152. Opko Health Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 153. Opko Health MRD (Minimal Residual Disease) Testing Product Offered
Table 154. Opko Health MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 155. Opko Health Main Business
Table 156. Opko Health Latest Developments
Table 157. Quest Diagnostics Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 158. Quest Diagnostics MRD (Minimal Residual Disease) Testing Product Offered
Table 159. Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 160. Quest Diagnostics Main Business
Table 161. Quest Diagnostics Latest Developments
Table 162. Sysmex Corporation Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 163. Sysmex Corporation MRD (Minimal Residual Disease) Testing Product Offered
Table 164. Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 165. Sysmex Corporation Main Business
Table 166. Sysmex Corporation Latest Developments
Table 167. Adaptive Biotechnologies Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 168. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product Offered
Table 169. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 170. Adaptive Biotechnologies Main Business
Table 171. Adaptive Biotechnologies Latest Developments
List of Figures
Figure 1. Picture of MRD (Minimal Residual Disease) Testing
Figure 2. MRD (Minimal Residual Disease) Testing Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global MRD (Minimal Residual Disease) Testing Sales Growth Rate 2016-2026 (Units)
Figure 7. Global MRD (Minimal Residual Disease) Testing Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. MRD (Minimal Residual Disease) Testing Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Flow Cytometry
Figure 10. Product Picture of Polymerase Chain Reaction (PCR)
Figure 11. Product Picture of Next-Generation Sequencing (NGS)
Figure 12. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Type in 2020
Figure 13. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2016-2021)
Figure 14. MRD (Minimal Residual Disease) Testing Consumed in Specialty Clinics and Hospitals
Figure 15. Global MRD (Minimal Residual Disease) Testing Market: Specialty Clinics and Hospitals (2016-2021) & (Units)
Figure 16. MRD (Minimal Residual Disease) Testing Consumed in Diagnostic Laboratories
Figure 17. Global MRD (Minimal Residual Disease) Testing Market: Diagnostic Laboratories (2016-2021) & (Units)
Figure 18. MRD (Minimal Residual Disease) Testing Consumed in Research Institutions
Figure 19. Global MRD (Minimal Residual Disease) Testing Market: Research Institutions (2016-2021) & (Units)
Figure 20. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2016-2021)
Figure 21. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Application in 2020
Figure 22. MRD (Minimal Residual Disease) Testing Revenue Market by Company in 2020 ($ Million)
Figure 23. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Company in 2020
Figure 24. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Regions (2016-2021)
Figure 25. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Region in 2020
Figure 26. Americas MRD (Minimal Residual Disease) Testing Sales 2016-2021 (Units)
Figure 27. Americas MRD (Minimal Residual Disease) Testing Revenue 2016-2021 ($ Millions)
Figure 28. APAC MRD (Minimal Residual Disease) Testing Sales 2016-2021 (Units)
Figure 29. APAC MRD (Minimal Residual Disease) Testing Revenue 2016-2021 ($ Millions)
Figure 30. Europe MRD (Minimal Residual Disease) Testing Sales 2016-2021 (Units)
Figure 31. Europe MRD (Minimal Residual Disease) Testing Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales 2016-2021 (Units)
Figure 33. Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue 2016-2021 ($ Millions)
Figure 34. Americas MRD (Minimal Residual Disease) Testing Sales Market Share by Country in 2020
Figure 35. Americas MRD (Minimal Residual Disease) Testing Revenue Market Share by Country in 2020
Figure 36. Americas MRD (Minimal Residual Disease) Testing Sales Market Share by Type in 2020
Figure 37. Americas MRD (Minimal Residual Disease) Testing Sales Market Share by Application in 2020
Figure 38. United States MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC MRD (Minimal Residual Disease) Testing Sales Market Share by Region in 2020
Figure 43. APAC MRD (Minimal Residual Disease) Testing Revenue Market Share by Regions in 2020
Figure 44. APAC MRD (Minimal Residual Disease) Testing Sales Market Share by Type in 2020
Figure 45. APAC MRD (Minimal Residual Disease) Testing Sales Market Share by Application in 2020
Figure 46. China MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 50. India MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Country in 2020
Figure 53. Europe MRD (Minimal Residual Disease) Testing Revenue Market Share by Country in 2020
Figure 54. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Type in 2020
Figure 55. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Application in 2020
Figure 56. Germany MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 57. France MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Country in 2020
Figure 62. Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Type in 2020
Figure 64. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Application in 2020
Figure 65. Egypt MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
